147 related articles for article (PubMed ID: 20940616)
1. Immunohistochemical study of 40 cases of longitudinal melanonychia.
Theunis A; Richert B; Sass U; Lateur N; Sales F; André J
Am J Dermatopathol; 2011 Feb; 33(1):27-34. PubMed ID: 20940616
[TBL] [Abstract][Full Text] [Related]
2. HMB-45 may be a more sensitive maker than S-100 or Melan-A for immunohistochemical diagnosis of primary oral and nasal mucosal melanomas.
Yu CH; Chen HH; Liu CM; Jeng YM; Wang JT; Wang YP; Liu BY; Sun A; Chiang CP
J Oral Pathol Med; 2005 Oct; 34(9):540-5. PubMed ID: 16138892
[TBL] [Abstract][Full Text] [Related]
3. Melanonychia, melanocytic hyperplasia, and nail melanoma in a Hispanic population.
Dominguez-Cherit J; Roldan-Marin R; Pichardo-Velazquez P; Valente C; Fonte-Avalos V; Vega-Memije ME; Toussaint-Caire S
J Am Acad Dermatol; 2008 Nov; 59(5):785-91. PubMed ID: 18804895
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical studies of conjunctival nevi and melanomas.
Jakobiec FA; Bhat P; Colby KA
Arch Ophthalmol; 2010 Feb; 128(2):174-83. PubMed ID: 20142539
[TBL] [Abstract][Full Text] [Related]
5. [Distribution of melanoma-associated antigens (HMB 45 and S 100) in benign and malignant melanocytic tumors of the conjunctiva].
Steuhl KP; Rohrbach JM; Knorr M
Klin Monbl Augenheilkd; 1991 Sep; 199(3):187-91. PubMed ID: 1753671
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical characteristics of melanoma.
Ohsie SJ; Sarantopoulos GP; Cochran AJ; Binder SW
J Cutan Pathol; 2008 May; 35(5):433-44. PubMed ID: 18399807
[TBL] [Abstract][Full Text] [Related]
7. Key point in dermoscopic differentiation between early nail apparatus melanoma and benign longitudinal melanonychia.
Koga H; Saida T; Uhara H
J Dermatol; 2011 Jan; 38(1):45-52. PubMed ID: 21175755
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study of HMB-45 monoclonal antibody uptake on various benign and malignant melanocytic lesions].
Lampert A; Thomine E; Lauret P; Hemet J
Ann Pathol; 1993; 13(2):100-7. PubMed ID: 8363667
[TBL] [Abstract][Full Text] [Related]
9. Melan-A/Mart-1 expression in various melanocytic lesions and in non-melanocytic soft tissue tumours.
Orosz Z
Histopathology; 1999 Jun; 34(6):517-25. PubMed ID: 10383696
[TBL] [Abstract][Full Text] [Related]
10. Differentiating neurotized melanocytic nevi from neurofibromas using Melan-A (MART-1) immunohistochemical stain.
Chen Y; Klonowski PW; Lind AC; Lu D
Arch Pathol Lab Med; 2012 Jul; 136(7):810-5. PubMed ID: 22742554
[TBL] [Abstract][Full Text] [Related]
11. [Immunohistochemical markers for cytoplasmic antigens in acquired melanosis, malignant melanomas, and nevi of the conjunctiva].
Hitzer S; Bialasiewicz AA; Richard G
Klin Monbl Augenheilkd; 1998 Oct; 213(4):230-7. PubMed ID: 9848068
[TBL] [Abstract][Full Text] [Related]
12. NGFR-positive desmoplastic melanomas with focal or absent S-100 staining: Further evidence supporting the use of both NGFR and S-100 as a primary immunohistochemical panel for the diagnosis of desmoplastic melanomas.
Radfar A; Stefanato CM; Ghosn S; Bhawan J
Am J Dermatopathol; 2006 Apr; 28(2):162-7. PubMed ID: 16625082
[TBL] [Abstract][Full Text] [Related]
13. Recurrent pigmented melanocytic nevus. A benign lesion, not to be mistaken for malignant melanoma.
Sexton M; Sexton CW
Arch Pathol Lab Med; 1991 Feb; 115(2):122-6. PubMed ID: 1992976
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and therapy of streaked nail pigmentation].
Baran R; Haneke E
Hautarzt; 1984 Jul; 35(7):359-65. PubMed ID: 6469639
[TBL] [Abstract][Full Text] [Related]
15. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis.
El Shabrawi-Caelen L; Kerl H; Cerroni L
Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366
[TBL] [Abstract][Full Text] [Related]
16. Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma.
Orchard GE
Histochem J; 2000 Aug; 32(8):475-81. PubMed ID: 11095072
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of the S100A1, S100B, CD44 and Bcl-2 antigens and the rate of cell proliferation assessed by Ki-67 antibody in benign and malignant melanocytic tumours.
Sviatoha V; Tani E; Kleina R; Sperga M; Skoog L
Melanoma Res; 2010 Apr; 20(2):118-25. PubMed ID: 20042890
[TBL] [Abstract][Full Text] [Related]
18. Subungual melanoma: histological examination of 50 cases from early stage to bone invasion.
Izumi M; Ohara K; Hoashi T; Nakayama H; Chiu CS; Nagai T; Matsubayashi J; Iwaya K; Mukai K
J Dermatol; 2008 Nov; 35(11):695-703. PubMed ID: 19120763
[TBL] [Abstract][Full Text] [Related]
19. A case of adult-onset longitudinal melanonychia due to nail matrix compound nevus.
Güneş P; Göktay F; Haneke E
J Cutan Pathol; 2020 Dec; 47(12):1159-1163. PubMed ID: 32640104
[TBL] [Abstract][Full Text] [Related]
20. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]